Literature DB >> 4517010

Suppression of lymphoma development in tetraparental AKR mouse chimaeras derived from ovum fusion.

R D Barnes, M Tuffrey, C E Ford.   

Abstract

Entities:  

Mesh:

Year:  1973        PMID: 4517010     DOI: 10.1038/newbio244282a0

Source DB:  PubMed          Journal:  Nat New Biol        ISSN: 0090-0028


× No keyword cloud information.
  8 in total

1.  Inhibition of AKR leukemogenesis by SMX-1, a dualtropic murine leukemia virus.

Authors:  E Stockert; P V O'Donnell; Y Obata; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1980-06       Impact factor: 11.205

2.  Lymphoma susceptibility of the AKR mouse strain acquired before the stage of implantation.

Authors:  R D Barnes; M Tuffrey
Journal:  Br J Cancer       Date:  1974-05       Impact factor: 7.640

3.  Failure to detect antibody against Gross virus in tetraparental AKR reversible CBA mouse chimaeras.

Authors:  R D Barnes; M Tuffrey; J Holliday
Journal:  Br J Cancer       Date:  1975-01       Impact factor: 7.640

4.  The lack of association of theta status and murine leukaemia virus content in the AKR.

Authors:  R D Barnes; K Brown
Journal:  Br J Cancer       Date:  1975-12       Impact factor: 7.640

5.  Murine leukaemia virus expression in the AKR following thymectomy.

Authors:  M Tuffrey; P Crewe; L Dawson; J Holliday; R D Barnes
Journal:  Br J Cancer       Date:  1975-10       Impact factor: 7.640

6.  A mouse gene on chromosome 5 that restricts infectivity of mink cell focus-forming recombinant murine leukemia viruses.

Authors:  J W Hartley; R A Yetter; H C Morse
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

7.  Murine leukaemia virus group-specific antigen in tumor-resistant tetraparental AKR reversible CBA/H-T6 chimaeras.

Authors:  R D Barnes; M Tuffrey; J Holliday; J H Hilgers; T Souissi
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

8.  The innate resistance of CBA mice to endogenous murine leukaemia virus infection.

Authors:  R D Barnes; M Tuffrey; E J Willis; G Mahouy; J Lasneret
Journal:  Br J Cancer       Date:  1976-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.